| Unifill Ready-to-Fill (Prefilled) Syringe |
|
The Unifill ready-to-fill (prefilled) syringe is the world’s first and only known prefilled syringe with automatic safety features fully integrated within the glass barrel. It is a primary drug container, a safety device and a needle containment system all rolled into one. The Unifill syringe is supplied as per standard handling systems for integration into fill-finish systems used for equivalent conventional prefilled syringes. Compared to ancillary safety products attached onto prefilled syringes, Unifill can help streamline fill-fill systems and significantly reduce transport, packaging, and storage costs. USP Class Six compliant materials reside within the drug-fluid path. The Unifill syringe is designed for safe, simple, and convenient use by either healthcare workers or patients who self-administer prescription medication. An audible, tactile click signals the injection of the full dose and the automatic activation of a needle retraction mechanism. Operators can control the speed of needle retraction directly from the body into the barrel of the syringe. The combination of automatic, operator-controlled retraction features within the Unifill syringe can help to virtually eliminate the risk of infection from needlestick injuries. The plunger is automatically locked after needle retraction, to prevent re-use of the device, circumvent product tampering, and encourage convenient and compact disposal. The Unifill syringe is now in production at Unilife’s production facilities in York, Pennsylvania, and available for supply to interested pharmaceutical parties for evaluation. Fill-Finish IntegrationThe Unifill syringe is supplied as per standard handling systems for integration into fill-finish systems used with equivalent ready-to-fill syringes. The Unifill syringe was designed to comply with standard processes used to fill, finish, and package conventional prefilled syringes with a measured liquid dose of up to 1mL in volume. Pharmaceutical customers receive the Unifill syringe in three sterile sub-assembly packaging configurations. The glass barrel sub-assembly configuration is supplied in a tub-and-tray system containing 160 units, with a loose Tyvek sheet and a Tyvek sealed lid. Unilife supplies plunger seals in an isolator port bag, and plunger sub-assemblies in a sealed plastic bag. Unilife is able to tailor its packaging configurations to meet specific customer needs. As a primary drug container that is similar in size to standard products, Unifill syringes can eliminate the costs and inefficiencies incurred by purchasing ancillary safety products that are attached onto standard prefilled syringes to comply with needlestick prevention laws. Drug StabilityThe Unifill syringe is a primary drug container designed for compatibility and stability with target prefilled injectable drugs and vaccines. Components within the drug fluid path are USP Class VI–compliant and tungsten-free. Unilife maintains relationships with many established material suppliers of ready-to-fill glass barrels, vials, and ampoules. To support customer branding preferences, many of our components can also be customized or supplied in various colors. For additional information regarding Unilife material selection options or to receive the Unifill syringe for compatibility and stability testing, please contact us at This e-mail address is being protected from spam bots, you need JavaScript enabled to view it . Integrated SafetyThe Unifill syringe is designed for intuitive use by either healthcare workers or patients, and offers compact handling, optimal protection, and convenient disposal. To virtually eliminate the risk of infection associated with potential blood-borne virus transmission modes such as needlestick injuries or aerosolization (splatter), the Unifill syringe incorporates an automatic (passive) safety mechanism that is fully integrated within the device. An audible, tactile click serves as a reliable end-of-dose indicator and a signal that the needle retraction mechanism has been activated. Operators can control the speed at which the needle is retracted from the body into the barrel by relieving thumb or finger pressure on the plunger. Upon the full withdrawal of the needle into the barrel, the plunger is automatically locked to prevent needle re-exposure, device re-use, or product tampering. Unifill syringes offer far more than compliance with needlestick prevention laws. They are designed to help to streamline injection procedures within healthcare facilities, improve patient compliance with therapy, and provide optimal protection to both the operator and others at risk of needlestick injuries. Such benefits can help to reduce healthcare costs and directly impact the commercial success and overall value of the drug-device combination product. Brand DifferentiationThe Unifill syringe sits at the leading edge of a unique technology platform of ready-to-ffill safety syringes developed by Unilife to protect healthcare workers, improve patient care, and optimize drug product lifecycles. The Unifill syringe is highly differentiated from ancillary safety products that are attached onto a standard prefilled syringe either by the pharmaceutical manufacturer or the operator. Such clip-on safety products can increase the bulk of a prefilled syringe by up to 60 to 70%, reducing its portability and capacity for compact handling by an operator. Some ancillary safety products also require an operator to undertake additional or non-intuitive steps of use during the injection of the dose or the activation of the safety mechanism. The Unifill syringe is intuitive for use by either healthcare workers or patients. Researchers conducting independent comparative evaluations of the Unifill syringe and leading ancillary safety products found that users strongly preferred Unifill for performance, intuitive use, safety, and design. Pharmaceutical companies can utilize the strengths of the Unifill syringe to help generate powerful brand differentiation for their brand-name, generic, or biosimilar drugs within competitive therapeutic markets to optimize product lifecycles and increase market share. Key Features
|
|
Sign up for email alerts |
